Leona C. Poon
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
Journal: American journal of obstetrics and gynecology
Published: April 21, 2015
Competing risks model in screening for preeclampsia by maternal characteristics and medical history.
Competing risks model in screening for preeclampsia by maternal characteristics and medical history.
Journal: American journal of obstetrics and gynecology
Published: November 08, 2014
Maternal serum anti-Müllerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia.
Journal: The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
Published: June 24, 2014
Early prediction of preeclampsia.
Journal: Obstetrics and gynecology international
Published: March 27, 2014
Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30-33 weeks' gestation.
Journal: Fetal diagnosis and therapy
Published: February 05, 2014
First-trimester maternal factors and biomarker screening for preeclampsia.
Journal: Prenatal diagnosis
Published: February 03, 2014
Competing risk model in screening for preeclampsia by mean arterial pressure and uterine artery pulsatility index at 30-33 weeks' gestation.
Journal: Fetal diagnosis and therapy
Published: January 10, 2014
Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks' gestation.
Journal: Fetal diagnosis and therapy
Published: December 08, 2013
Maternal serum placental growth factor isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks' gestation in late-onset pre-eclampsia and small for gestational age neonates.
Journal: Fetal diagnosis and therapy
Published: December 05, 2013
Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks' gestation.
Journal: Fetal diagnosis and therapy
Published: November 25, 2013
Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13 weeks' gestation in normal and pathological pregnancies.
Journal: Fetal diagnosis and therapy
Published: November 06, 2013
Prediction of preeclampsia by uterine artery Doppler at 20-24 weeks' gestation.
Journal: Fetal diagnosis and therapy
Published: September 12, 2013
Last Updated: 09/26/2026